Amgen’s (AMGN) closely watched cardiovascular drug candidate lost a major rival on Sept. 4, when Novartis (NVS) announced that its...
Global trade, energy transition, financial regulation, multinational corporations, and macroeconomic trends.
Categories
Recent Posts
- Vanguard's growth ETF turned terrible timing into $100K
- Nedbank’s R13.9bn NCBA East Africa deal complete
- Billionaire Elon Musk says he’ll give every kid in America shares of SpaceX next year
- Warren Buffett's Berkshire raises stake in Lennar amid slowing housing demand
- France’s bonds drop as rioting heaps pressure on government